Analyst Expectations For American Healthcare REIT's Future
10 analysts have expressed a variety of opinions on American Healthcare REIT (NYSE:AHR) over the past quarter, offering a diverse set of opinions from bullish to bearish.
In the table below, you'll find a summary of their recent ratings, revealing the shifting sentiments over the past 30 days and comparing them to the previous months.
| Bullish | Somewhat Bullish | Indifferent | Somewhat Bearish | Bearish | |
|---|---|---|---|---|---|
| Total Ratings | 3 | 6 | 1 | 0 | 0 |
| Last 30D | 0 | 1 | 0 | 0 | 0 |
| 1M Ago | 1 | 0 | 0 | 0 | 0 |
| 2M Ago | 0 | 0 | 0 | 0 | 0 |
| 3M Ago | 2 | 5 | 1 | 0 | 0 |
Analysts have set 12-month price targets for American Healthcare REIT, revealing an average target of $54.7, a high estimate of $60.00, and a low estimate of $52.00. Observing a 13.96% increase, the current average has risen from the previous average price target of $48.00.
Analyzing Analyst Ratings: A Detailed Breakdown
The standing of American Healthcare REIT among financial experts becomes clear with a thorough analysis of recent analyst actions. The summary below outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.
| Analyst | Analyst Firm | Action Taken | Rating | Current Price Target | Prior Price Target |
|---|---|---|---|---|---|
| Juan Sanabria | BMO Capital | Announces | Outperform | $55.00 | - |
| Michael Lewis | Truist Securities | Lowers | Buy | $52.00 | $53.00 |
| Michael Lewis | Truist Securities | Raises | Buy | $53.00 | $46.00 |
| Nick Joseph | Citigroup | Raises | Neutral | $52.00 | $45.00 |
| Ronald Kamdem | Morgan Stanley | Raises | Overweight | $55.00 | $52.00 |
| Michael Goldsmith | UBS | Raises | Buy | $56.00 | $51.00 |
| Nicholas Yulico | Scotiabank | Raises | Sector Outperform | $55.00 | $47.00 |
| Austin Wurschmidt | Keybanc | Raises | Overweight | $55.00 | $43.00 |
| Michael Carroll | RBC Capital | Raises | Outperform | $54.00 | $45.00 |
| Aaron Hecht | Citizens | Raises | Market Outperform | $60.00 | $50.00 |
Key Insights:
- Action Taken: In response to dynamic market conditions and company performance, analysts update their recommendations. Whether they 'Maintain', 'Raise', or 'Lower' their stance, it signifies their reaction to recent developments related to American Healthcare REIT. This insight gives a snapshot of analysts' perspectives on the current state of the company.
- Rating: Offering insights into predictions, analysts assign qualitative values, from 'Outperform' to 'Underperform'. These ratings convey expectations for the relative performance of American Healthcare REIT compared to the broader market.
- Price Targets: Understanding forecasts, analysts offer estimates for American Healthcare REIT's future value. Examining the current and prior targets provides insight into analysts' changing expectations.
Capture valuable insights into American Healthcare REIT's market standing by understanding these analyst evaluations alongside pertinent financial indicators. Stay informed and make strategic decisions with our Ratings Table.
Stay up to date on American Healthcare REIT analyst ratings.
Unveiling the Story Behind American Healthcare REIT
American Healthcare REIT Inc is a healthcare-focused real estate investment trust. It owns a diversified portfolio of clinical healthcare real estate properties, focusing on medical office buildings, skilled nursing facilities, senior housing, hospitals, and other healthcare-related facilities. It has four reportable business segments: integrated senior health campuses, outpatient medical, triple-net leased properties and SHOP. It generates majority of its revenue through Integrated Senior Health Campuses segment.
American Healthcare REIT's Financial Performance
Market Capitalization: With restricted market capitalization, the company is positioned below industry averages. This reflects a smaller scale relative to peers.
Positive Revenue Trend: Examining American Healthcare REIT's financials over 3M reveals a positive narrative. The company achieved a noteworthy revenue growth rate of 9.38% as of 30 September, 2025, showcasing a substantial increase in top-line earnings. As compared to competitors, the company encountered difficulties, with a growth rate lower than the average among peers in the Real Estate sector.
Net Margin: The company's net margin is a standout performer, exceeding industry averages. With an impressive net margin of 9.76%, the company showcases strong profitability and effective cost control.
Return on Equity (ROE): American Healthcare REIT's ROE stands out, surpassing industry averages. With an impressive ROE of 2.19%, the company demonstrates effective use of equity capital and strong financial performance.
Return on Assets (ROA): American Healthcare REIT's ROA surpasses industry standards, highlighting the company's exceptional financial performance. With an impressive 1.21% ROA, the company effectively utilizes its assets for optimal returns.
Debt Management: The company maintains a balanced debt approach with a debt-to-equity ratio below industry norms, standing at 0.63.
Analyst Ratings: What Are They?
Analysts are specialists within banking and financial systems that typically report for specific stocks or within defined sectors. These people research company financial statements, sit in conference calls and meetings, and speak with relevant insiders to determine what are known as analyst ratings for stocks. Typically, analysts will rate each stock once a quarter.
Some analysts publish their predictions for metrics such as growth estimates, earnings, and revenue to provide additional guidance with their ratings. When using analyst ratings, it is important to keep in mind that stock and sector analysts are also human and are only offering their opinions to investors.
This article was generated by Benzinga's automated content engine and reviewed by an editor.